INVIVO SE-75 BINDING TO HUMAN PLASMA-PROTEINS AFTER ADMINISTRATION OF SE-75(O2/3)
INVIVO SE-75 BINDING TO HUMAN PLASMA-PROTEINS AFTER ADMINISTRATION OF SE-75(O2/3)
复制标题
DOI:
10.1016/0304-4165(74)90188-3
复制
发表时间:
1974-01-01
期刊:
影响因子:
--
通讯作者:
BURK, RF
中科院分区:
文献类型:
--
作者:
BURK, RF
Binding of7 5Se to plasma proteins was studied in four cancer patients who received 200–250 μCi of7 5SeO32−(1.25 μg of selenium) intravenously for tumor scans. During the hour after injection, the7 5Se disappeared rapidly from the plasma. Gel filtration chromatography and dialysis experiments indicated that a large amount of the7 5Se returned to the plasma bound to protein between 1 and 6 h after injection. Up to 16% of the plasma7 5Se was found in very-low-density lipoproteins and low-density lipoproteins as early as 3 mikn after injection but very little7 5Se was found in high density lipoproteins. The very low density lipoprotein7 5Se activity declined very rapidly whereas low density lipoprotein7 5Se activity fell more slowly. Zonal ultracentrifugal studies of one subject's lipoproteins revealed a continuum of7 5Se-binding proteins from the very low density lipoprotein peak to the low density lipoprotein peak. Most of the7 5Se could be removed from the lipoproteins by denaturation with 8 M urea or treatment with 0.5 M mercaptoethanol. These treatments removed very little of the7 5Se from plasma collected 48 h after injection indicating a different type of binding of selenium in lipoproteins than in other plasma proteins.